These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14674127)

  • 1. [Radioimmunotherapy in patients with ovarian cancer in complete remission after the first line surgery and chemotherapy after second look laparoscopy procedure].
    Markowska J; Madry R; Kierzkowski J; Malicki J; Roszak A; Lubin J; Bratos K
    Ginekol Pol; 2003 Sep; 74(9):799-804. PubMed ID: 14674127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody.
    Juweid M; Sharkey RM; Alavi A; Swayne LC; Herskovic T; Hanley D; Rubin AD; Pereira M; Goldenberg DM
    J Nucl Med; 1997 Feb; 38(2):257-60. PubMed ID: 9025751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma.
    Mahé MA; Fumoleau P; Fabbro M; Guastalla JP; Faurous P; Chauvot P; Chetanoud L; Classe JM; Rouanet P; Chatal JF
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3249s-3253s. PubMed ID: 10541371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer.
    Crippa F; Bolis G; Seregni E; Gavoni N; Scarfone G; Ferraris C; Buraggi GL; Bombardieri E
    Eur J Cancer; 1995; 31A(5):686-90. PubMed ID: 7640039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.
    Oei AL; Verheijen RH; Seiden MV; Benigno BB; Lopes A; Soper JT; Epenetos AA; Massuger LF
    Int J Cancer; 2007 Jun; 120(12):2710-4. PubMed ID: 17354223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of laparoscopy as a second-look method in neoplasms of the ovary].
    Martí Vicente A; Sainz S; Soriano G; Ojeda B; Méndez C; Alonso C; Cussó X
    Rev Esp Enferm Dig; 1990 Apr; 77(4):275-8. PubMed ID: 2143914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission.
    Verheijen RH; Massuger LF; Benigno BB; Epenetos AA; Lopes A; Soper JT; Markowska J; Vyzula R; Jobling T; Stamp G; Spiegel G; Thurston D; Falke T; Lambert J; Seiden MV
    J Clin Oncol; 2006 Feb; 24(4):571-8. PubMed ID: 16446329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study.
    Nicoletto MO; Tumolo S; Talamini R; Salvagno L; Franceschi S; Visonà E; Marin G; Angelini F; Brigato G; Scarabelli C; Carbone A; Cecchetto A; Prosperi A; Rosabian A; Giusto M; Cima GP; Morassut S; Nascimben O; Vinante O; Fiorentino MV
    J Clin Oncol; 1997 Mar; 15(3):994-9. PubMed ID: 9060538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal alpha-particle radioimmunotherapy of ovarian cancer patients: pharmacokinetics and dosimetry of (211)At-MX35 F(ab')2--a phase I study.
    Andersson H; Cederkrantz E; Bäck T; Divgi C; Elgqvist J; Himmelman J; Horvath G; Jacobsson L; Jensen H; Lindegren S; Palm S; Hultborn R
    J Nucl Med; 2009 Jul; 50(7):1153-60. PubMed ID: 19525452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen monoclonal antibodies.
    Juweid M; Swayne LC; Sharkey RM; Dunn R; Rubin AD; Herskovic T; Goldenberg DM
    Gynecol Oncol; 1997 Dec; 67(3):259-71. PubMed ID: 9441773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second look for ovarian cancer: laparoscopy or Laparotomy? A prospective comparative study.
    Clough KB; Ladonne JM; Nos C; Renolleau C; Validire P; Durand JC
    Gynecol Oncol; 1999 Mar; 72(3):411-7. PubMed ID: 10053115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
    McCreath WA; Eisenhauer EL; Abu-Rustum NR; Venkatraman ES; Caceres A; Bier R; Huh J; Cho J; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Jul; 102(1):8-14. PubMed ID: 16427689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic second look operation for ovarian cancer: single center experiences.
    Hong DG; Park NY; Chong GO; Cho YL; Park IS; Lee YS
    Minim Invasive Ther Allied Technol; 2011 Dec; 20(6):346-51. PubMed ID: 21413836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second-look in ovarian cancer: laparoscopy or laparotomy?].
    Russo A; Cirelli G; Cassese E; Delli Ponti D; Sgambato R; Cecere F; Zarcone R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):146-54. PubMed ID: 11526711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.
    Alvarez RD; Huh WK; Khazaeli MB; Meredith RF; Partridge EE; Kilgore LC; Grizzle WE; Shen S; Austin JM; Barnes MN; Carey D; Schlom J; LoBuglio AF
    Clin Cancer Res; 2002 Sep; 8(9):2806-11. PubMed ID: 12231520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing single-agent carboplatin with carboplatin followed by radiotherapy for advanced ovarian cancer: a North Thames Ovary Group study.
    Lambert HE; Rustin GJ; Gregory WM; Nelstrop AE
    J Clin Oncol; 1993 Mar; 11(3):440-8. PubMed ID: 8445418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.
    Morschhauser F; Radford J; Van Hoof A; Botto B; Rohatiner AZ; Salles G; Soubeyran P; Tilly H; Bischof-Delaloye A; van Putten WL; Kylstra JW; Hagenbeek A
    J Clin Oncol; 2013 Jun; 31(16):1977-83. PubMed ID: 23547079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of colonic and ovarian cancer with radioactive monoclonal antibodies against the CA l9-9 and CA 125 antigens].
    Graef A; Romero MA; González M; Pierzo JA; Sosa R; Altamirano P
    Gac Med Mex; 1992; 128(2):91-5. PubMed ID: 1302216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Second-look operation or second-look laparoscopy for evaluating complete remission of ovarian cancer].
    Krafft W; König EM; Schirmer A; Müller U
    Zentralbl Gynakol; 1990; 112(12):767-71. PubMed ID: 1699368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.